“At the end of the practice, statistically significant improvements were observed in sleep efficiency, total sleep time, total wake time, sleep onset latency or the time it takes to fall asleep ...

Of survey respondents, 47% said large number and large size of pills were among top phosphate binder adherence barriers. An investigational agent is smaller, swallowed whole and dosed with fewer ...

The number of victims who died after a roof collapsed ... Forensic Pathology officials read the names of 54 victims they had identified so far. “We cannot wait until nighttime!” ...

Scientists have identified a key vulnerability in pancreatic cancer by targeting transcription ... The patients experienced up to a 49% shrinkage in their liver metastases after taking the City of ...

"The US has lower capacity to manufacture generic products while European manufacturers are largely working on innovative/patented products. Furthermore, the lower costs, higher number of USFDA ...

Nytol, available in 25mg and 50mg pills, should only be taken for a maximum period of two weeks, with one tablet taken within 24-hours, according to safety guidance on the patient information leaflet.

Dan Gooding is a Newsweek reporter based in New York City. His focus is reporting on immigration and border security. He has covered immigration issues extensively, including the root causes of ...

including making the morning-after pill free at NHS pharmacies and boosting financial incentives for pharmacists to identify patients with undiagnosed high blood pressure to take pressure off GPs.

The morning-after pill is set to become available for free in pharmacies across England in a bid to end the 'unfair postcode lottery' for women, the government has said. Emergency contraception ...

Women across England will be able to get the morning-after pill for free from pharmacies from later this year, the government has said. Emergency contraception is already free of charge from most ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...